John Glenn serves as the Chief Financial Officer (CFO) at IRADIMED CORPORATION, a company specializing in the development, manufacture, and distribution of innovative magnetic resonance imaging (MRI) compatible medical devices. In his role as CFO, Glenn is responsible for overseeing the financial operations of the company, including financial planning and analysis, accounting, and investor relations. His strategic vision and financial acumen have been instrumental in guiding IRADIMED through periods of growth and expansion, ensuring the company remains financially robust while continuing to innovate in the medical device sector. Prior to joining IRADIMED, John Glenn held various senior financial positions at several prominent organizations within the healthcare and technology industries. His career is marked by a series of notable achievements, including the successful implementation of financial systems that enhanced operational efficiency and the execution of strategic initiatives that significantly increased shareholder value. Glenn's expertise in financial management and his deep understanding of the healthcare sector have made him a valuable asset to IRADIMED, where he continues to drive the company's financial strategy and contribute to its overall success. In addition to his professional responsibilities, John Glenn is known for his commitment to fostering a culture of transparency and accountability within IRADIMED. Under his leadership, the company has maintained a strong focus on ethical financial practices and has been recognized for its dedication to corporate governance. Glenn's leadership style emphasizes collaboration and innovation, which has helped IRADIMED to not only meet but exceed its financial goals, solidifying its position as a leader in the MRI-compatible medical device market.